EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
AND WHEREAS Oncolytics and the Employee entered into an Executive Employment Agreement dated January 1, 2013, which has been amended;
EMPLOYMENT AGREEMENTEmployment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (“Agreement”), effective November 1, 2018 (“Effective Date”), is made between Oncolytics Biotech (U.S.), Inc., (“Employer” or the “Company”), and Rita Laeufle, MD PhD (“Employee”). Employee and the Company are sometimes referred to herein as the “Parties.”
AMENDING AGREEMENT #1Executive Employment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
WHEREAS Oncolytics and the Employee entered into an Executive Employment Agreement dated January 1, 2019 (the “Employment Agreement”);
AMENDING AGREEMENT #1Employment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
WHEREAS the Employee is an officer of OBUS whose terms of employment are set forth in the Employment Agreement dated effective November 1, 2018, (the “Employment Agreement”);
AMENDING AGREEMENTEmployment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
NOW THEREFORE in consideration of the mutual covenants contained in this Amending Agreement, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is agreed as follows:
AMENDING AGREEMENT #3Employment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
WHEREAS the Employee is an officer of OBUS whose terms of employment are set forth in the Employment Agreement dated effective June 29, 2017, as amended by Amending Agreement #1 and Amending Agreement #2 (collectively the “Employment Agreement”);
EMPLOYMENT AGREEMENTEmployment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
AMENDING AGREEMENT #4Employment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
WHEREAS the Employee is an officer of OBUS whose terms of employment are set forth in the Employment Agreement dated effective June 29, 2017, which has been amended by Amending Agreements (collectively the “Employment Agreement”);
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
AND WHEREAS Oncolytics and the Employee entered into an Executive Employment Agreement dated January 1, 2013, which has been amended;
EMPLOYMENT AGREEMENTEmployment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
AMENDING AGREEMENTEmployment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
AND WHEREAS Oncolytics and the Employee entered into an Employment Agreement dated August 1, 2013, which has been amended (collectively the “Employment Agreement”);
AMENDING AGREEMENT NO. 1 THIS AMENDING AGREEMENT made effective as of the 1st day of December, 2015. BETWEEN:Employment Agreement • March 6th, 2020 • Oncolytics Biotech Inc • Pharmaceutical preparations
